Modeling the Gibbs-Donnan effect during ultrafiltration and diafiltration processes using the Poisson-Boltzmann theory in combination with a basic Stern model
被引:23
作者:
Briskot, Till
论文数: 0引用数: 0
h-index: 0
机构:
GoSilico GmbH, Kriegsstr 240, D-76135 Karlsruhe, Germany
KIT, Inst Engn Life Sci, Sect Biomol Separat Engn 4, Fritz Haber Weg 2, D-76131 Karlsruhe, Germany
Boehringer Ingelheim Pharma GmbH & Co KG, Late Stage DSP Dev, D-88397 Biberach, GermanyGoSilico GmbH, Kriegsstr 240, D-76135 Karlsruhe, Germany
The Gibbs-Donnan effect is a well-known phenomenon causing ions to be distributed unevenly across semipermeable membranes that are permeable to ions but not to larger macromolecules such as proteins. In protein ultrafiltration and diafiltration (UF/DF) processes, this effect often leads to discrepancies between the pH and excipient concentrations in the final drug substance and in the DF buffer.& nbsp;In this work, a model describing the retentate and permeate composition throughout combined UF/DF processes is introduced. The model accounts for volume exclusion effects and electrostatic interactions between ions and the protein based on the Poisson-Boltzmann theory in combination with a basic Stern model. Advantages and limitations of the proposed model were analyzed using UF/DF experiments with multiple diafiltration buffers and proteins. A comparison between simulated and experimental permeate data showed good agreement for low to moderate Donnan potentials but model limitations for high Donnan potentials at protein concentration larger 100 gL(-1). In contrast, simulated retentate data showed good agreement for both low and high Donnan potentials and for protein concentrations up to 190 gL(-1). It was demonstrated that in this high protein concentration regime, the applied basic Stern model provides more accurate predictions compared to previous theories based on the Poisson-Boltzmann theory alone. This makes the model a valuable tool to describe discrepancies between pH and excipient concentrations in the final drug substance and DF buffer for highly concentrated protein formulations. As model predictions are based solely on structural information on the protein and the composition of the DF buffer, the model is particularly beneficial at an early stage in process development to streamline process development and improve process understanding.
机构:
Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem Engn & Tech Safety, Vecna Pot 113, Ljubljana 1000, SloveniaUniv Ljubljana, Fac Chem & Chem Technol, Dept Chem Engn & Tech Safety, Vecna Pot 113, Ljubljana 1000, Slovenia
Ambrozic, Rok
;
Arzensek, Dejan
论文数: 0引用数: 0
h-index: 0
机构:
Lek Pharmaceut Dd, Tech Dev Biosimilars, Tech Res Dev Novartis, Menges, SloveniaUniv Ljubljana, Fac Chem & Chem Technol, Dept Chem Engn & Tech Safety, Vecna Pot 113, Ljubljana 1000, Slovenia
Arzensek, Dejan
;
Podgornik, Ales
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem Engn & Tech Safety, Vecna Pot 113, Ljubljana 1000, SloveniaUniv Ljubljana, Fac Chem & Chem Technol, Dept Chem Engn & Tech Safety, Vecna Pot 113, Ljubljana 1000, Slovenia
机构:
Penn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USAPenn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USA
Emami, Parinaz
;
Singh, Nripen
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb, Global Prod Dev & Supply, Devens, MA USAPenn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USA
Singh, Nripen
;
Ilott, Andrew
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Drug Prod Sci & Technol, Global Prod & Supply, New Brunswick, NJ USAPenn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USA
Ilott, Andrew
;
Sahin, Erinc
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Drug Prod Sci & Technol, Global Prod & Supply, New Brunswick, NJ USAPenn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USA
Sahin, Erinc
;
Zydney, Andrew
论文数: 0引用数: 0
h-index: 0
机构:
Penn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USAPenn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USA
机构:
Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem Engn & Tech Safety, Vecna Pot 113, Ljubljana 1000, SloveniaUniv Ljubljana, Fac Chem & Chem Technol, Dept Chem Engn & Tech Safety, Vecna Pot 113, Ljubljana 1000, Slovenia
Ambrozic, Rok
;
Arzensek, Dejan
论文数: 0引用数: 0
h-index: 0
机构:
Lek Pharmaceut Dd, Tech Dev Biosimilars, Tech Res Dev Novartis, Menges, SloveniaUniv Ljubljana, Fac Chem & Chem Technol, Dept Chem Engn & Tech Safety, Vecna Pot 113, Ljubljana 1000, Slovenia
Arzensek, Dejan
;
Podgornik, Ales
论文数: 0引用数: 0
h-index: 0
机构:
Univ Ljubljana, Fac Chem & Chem Technol, Dept Chem Engn & Tech Safety, Vecna Pot 113, Ljubljana 1000, SloveniaUniv Ljubljana, Fac Chem & Chem Technol, Dept Chem Engn & Tech Safety, Vecna Pot 113, Ljubljana 1000, Slovenia
机构:
Penn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USAPenn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USA
Emami, Parinaz
;
Singh, Nripen
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb, Global Prod Dev & Supply, Devens, MA USAPenn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USA
Singh, Nripen
;
Ilott, Andrew
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Drug Prod Sci & Technol, Global Prod & Supply, New Brunswick, NJ USAPenn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USA
Ilott, Andrew
;
Sahin, Erinc
论文数: 0引用数: 0
h-index: 0
机构:
Bristol Myers Squibb Co, Drug Prod Sci & Technol, Global Prod & Supply, New Brunswick, NJ USAPenn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USA
Sahin, Erinc
;
Zydney, Andrew
论文数: 0引用数: 0
h-index: 0
机构:
Penn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USAPenn State Univ, Dept Chem Engn, Univ Pk, State Coll, PA 16802 USA